rs2230587

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002227.4(JAK1):​c.2049C>T​(p.Ser683=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.131 in 1,613,782 control chromosomes in the GnomAD database, including 15,107 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 1853 hom., cov: 32)
Exomes 𝑓: 0.13 ( 13254 hom. )

Consequence

JAK1
NM_002227.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.92
Variant links:
Genes affected
JAK1 (HGNC:6190): (Janus kinase 1) This gene encodes a membrane protein that is a member of a class of protein-tyrosine kinases (PTK) characterized by the presence of a second phosphotransferase-related domain immediately N-terminal to the PTK domain. The encoded kinase phosphorylates STAT proteins (signal transducers and activators of transcription) and plays a key role in interferon-alpha/beta, interferon-gamma, and cytokine signal transduction. This gene plays a crucial role in effecting the expression of genes that mediate inflammation, epithelial remodeling, and metastatic cancer progression. This gene is a key component of the interleukin-6 (IL-6)/JAK1/STAT3 immune and inflammation response and is a therapeutic target for alleviating cytokine storms. The kinase activity of this gene is directly inhibited by the suppressor of cytokine signalling 1 (SOCS1) protein. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 1-64845579-G-A is Benign according to our data. Variant chr1-64845579-G-A is described in ClinVar as [Benign]. Clinvar id is 1169783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.92 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.301 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
JAK1NM_002227.4 linkuse as main transcriptc.2049C>T p.Ser683= synonymous_variant 15/25 ENST00000342505.5 NP_002218.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
JAK1ENST00000342505.5 linkuse as main transcriptc.2049C>T p.Ser683= synonymous_variant 15/255 NM_002227.4 ENSP00000343204 A1

Frequencies

GnomAD3 genomes
AF:
0.151
AC:
22992
AN:
151954
Hom.:
1850
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.197
Gnomad AMI
AF:
0.192
Gnomad AMR
AF:
0.156
Gnomad ASJ
AF:
0.135
Gnomad EAS
AF:
0.313
Gnomad SAS
AF:
0.155
Gnomad FIN
AF:
0.130
Gnomad MID
AF:
0.0981
Gnomad NFE
AF:
0.114
Gnomad OTH
AF:
0.142
GnomAD3 exomes
AF:
0.150
AC:
37484
AN:
249582
Hom.:
3241
AF XY:
0.146
AC XY:
19832
AN XY:
135408
show subpopulations
Gnomad AFR exome
AF:
0.203
Gnomad AMR exome
AF:
0.176
Gnomad ASJ exome
AF:
0.131
Gnomad EAS exome
AF:
0.316
Gnomad SAS exome
AF:
0.158
Gnomad FIN exome
AF:
0.124
Gnomad NFE exome
AF:
0.114
Gnomad OTH exome
AF:
0.133
GnomAD4 exome
AF:
0.129
AC:
189012
AN:
1461710
Hom.:
13254
Cov.:
33
AF XY:
0.130
AC XY:
94197
AN XY:
727156
show subpopulations
Gnomad4 AFR exome
AF:
0.199
Gnomad4 AMR exome
AF:
0.176
Gnomad4 ASJ exome
AF:
0.131
Gnomad4 EAS exome
AF:
0.295
Gnomad4 SAS exome
AF:
0.159
Gnomad4 FIN exome
AF:
0.127
Gnomad4 NFE exome
AF:
0.116
Gnomad4 OTH exome
AF:
0.146
GnomAD4 genome
AF:
0.151
AC:
23015
AN:
152072
Hom.:
1853
Cov.:
32
AF XY:
0.154
AC XY:
11415
AN XY:
74330
show subpopulations
Gnomad4 AFR
AF:
0.197
Gnomad4 AMR
AF:
0.156
Gnomad4 ASJ
AF:
0.135
Gnomad4 EAS
AF:
0.314
Gnomad4 SAS
AF:
0.156
Gnomad4 FIN
AF:
0.130
Gnomad4 NFE
AF:
0.114
Gnomad4 OTH
AF:
0.140
Alfa
AF:
0.130
Hom.:
968
Bravo
AF:
0.157
Asia WGS
AF:
0.231
AC:
800
AN:
3478
EpiCase
AF:
0.109
EpiControl
AF:
0.109

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanNov 12, 2023This variant is classified as Benign based on local population frequency. This variant was detected in 26% of patients studied by a panel of primary immunodeficiencies. Number of patients: 25. Only high quality variants are reported. -
JAK1-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJul 08, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.52
DANN
Benign
0.40
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2230587; hg19: chr1-65311262; COSMIC: COSV61087573; COSMIC: COSV61087573; API